COMPARISON OF THE EFFECTS OF DOXAZOSIN AND ATENOLOL ON BLOOD-PRESSURE AND BLOOD-LIPIDS - A ONE-YEAR, DOUBLE-BLIND-STUDY IN 228 HYPERTENSIVE PATIENTS

被引：35

作者：

TALSETH, T

WESTLIE, L

DAAE, L

VATLE, S

机构：

来源：

AMERICAN HEART JOURNAL | 1988年 / 116卷 / 06期

关键词：

D O I：

10.1016/0002-8703(88)90231-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1790 / 1796

页数：7

共 25 条

[1] THE ALPHA-1-ADRENOCEPTOR ANTAGONIST PROFILE OF DOXAZOSIN - PRECLINICAL PHARMACOLOGY [J].

ALABASTER, VA ;

DAVEY, MJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S9-S17

[2] METABOLIC DISTURBANCES INCREASING THE RISK OF CORONARY HEART-DISEASE DURING DIURETIC-BASED ANTIHYPERTENSIVE THERAPY - LIPID ALTERATIONS AND GLUCOSE-INTOLERANCE [J].

AMES, RP .

AMERICAN HEART JOURNAL, 1983, 106 (05) :1207-1214

[3] INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].

CASTELLI, WP ;

GARRISON, RJ ;

WILSON, PWF ;

ABBOTT, RD ;

KALOUSDIAN, S ;

KANNEL, WB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838

[4]

CONRAD KA, 1988, IN PRESS EUR J CLIN

[5] A COMPARISON OF METHODS FOR THE ESTIMATION OF PLASMA LOW-DENSITY AND VERY LOW-DENSITY-LIPOPROTEIN CHOLESTEROL - THE LIPID-RESEARCH-CLINICS PREVALENCE STUDY [J].

DELONG, DM ;

DELONG, ER ;

WOOD, PD ;

LIPPEL, K ;

RIFKIND, BM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (17) :2372-2377

[6] SERUM-LIPID CHANGES IN A ONE-YEAR, MULTICENTER, DOUBLE-BLIND COMPARISON OF DOXAZOSIN AND ATENOLOL FOR MILD TO MODERATE ESSENTIAL-HYPERTENSION [J].

FRICK, MH ;

COX, DA ;

HIMANEN, P ;

HUTTUNEN, M ;

PITKAJARVI, T ;

PORSTI, P ;

POYHONEN, L ;

PYYKONEN, ML ;

REINKAINEN, P ;

SALMELA, P ;

SARASTE, M .

AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (14) :G61-G67

[7] A LONG-TERM DOUBLE-BLIND COMPARISON OF DOXAZOSIN AND ATENOLOL IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION [J].

FRICK, MH ;

HALTTUNEN, P ;

HIMANEN, P ;

HUTTUNEN, M ;

PORSTI, P ;

PITKAJARVI, T ;

POYHONEN, L ;

PYYKONEN, ML ;

REINIKAINEN, P ;

SALMELA, P ;

SARASTE, M .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S55-S62

[8] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].

FRICK, MH ;

ELO, O ;

HAAPA, K ;

HEINONEN, OP ;

HEINSALMI, P ;

HELO, P ;

HUTTUNEN, JK ;

KAITANIEMI, P ;

KOSKINEN, P ;

MANNINEN, V ;

MAENPAA, H ;

MALKONEN, M ;

MANTTARI, M ;

NOROLA, S ;

PASTERNACK, A ;

PIKKARAINEN, J ;

ROMO, M ;

SJOBLOM, T ;

NIKKILA, EA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245

[9] HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].

GORDON, T ;

CASTELLI, WP ;

HJORTLAND, MC ;

KANNEL, WB ;

DAWBER, TR .

AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714

[10]

HJORTDAHL P, 1987, ACTA MED SCAND, V221, P427

← 1 2 3 →